| Autor: |
Ahmed, Kamal, Ahmed, Elsheaita, Mahmoud, Abdelnabi |
| Rok vydání: |
2022 |
| Předmět: |
|
| Zdroj: |
World Journal of Clinical Cases. 10:1764-1774 |
| ISSN: |
2307-8960 |
| DOI: |
10.12998/wjcc.v10.i6.1764 |
| Popis: |
Since direct-acting antiviral agents (DAAs) have been introduced into hepatitis C virus treatment, the sustained viral response (SVR) rate has significantly increased to more than 95%. Scientific evidence supports the idea that SVR after interferon therapy has beneficial effects related to cirrhosis progression, resulting in a reduction in the incidence of hepatocellular carcinoma (HCC). However, a significant debate exists related to DAA impact on HCC development. We reviewed the current literature highlighting the controversial data related to DAA association with |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
